Global Heparin API Market Research Report 2021

1 Heparin API Market Overview
1.1 Product Overview and Scope of Heparin API
1.2 Heparin API Segment by Type
1.2.1 Global Heparin API Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Heparin Sodium
1.2.3 Heparin Calcium
1.2.4 Other
1.3 Heparin API Segment by Application
1.3.1 Heparin API Sales Comparison by Application: (2021-2027)
1.3.2 UFH
1.3.3 LMWH
1.4 Global Heparin API Market Size Estimates and Forecasts
1.4.1 Global Heparin API Revenue 2016-2027
1.4.2 Global Heparin API Sales 2016-2027
1.4.3 Heparin API Market Size by Region: 2016 Versus 2021 Versus 2027

2 Heparin API Market Competition by Manufacturers
2.1 Global Heparin API Sales Market Share by Manufacturers (2016-2021)
2.2 Global Heparin API Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Heparin API Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Heparin API Manufacturing Sites, Area Served, Product Type
2.5 Heparin API Market Competitive Situation and Trends
2.5.1 Heparin API Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Heparin API Players Market Share by Revenue
2.5.3 Global Heparin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Heparin API Retrospective Market Scenario by Region
3.1 Global Heparin API Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Heparin API Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Heparin API Market Facts & Figures by Country
3.3.1 North America Heparin API Sales by Country
3.3.2 North America Heparin API Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Heparin API Market Facts & Figures by Country
3.4.1 Europe Heparin API Sales by Country
3.4.2 Europe Heparin API Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Heparin API Market Facts & Figures by Region
3.5.1 Asia Pacific Heparin API Sales by Region
3.5.2 Asia Pacific Heparin API Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Heparin API Market Facts & Figures by Country
3.6.1 Latin America Heparin API Sales by Country
3.6.2 Latin America Heparin API Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Heparin API Market Facts & Figures by Country
3.7.1 Middle East and Africa Heparin API Sales by Country
3.7.2 Middle East and Africa Heparin API Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Heparin API Historic Market Analysis by Type
4.1 Global Heparin API Sales Market Share by Type (2016-2021)
4.2 Global Heparin API Revenue Market Share by Type (2016-2021)
4.3 Global Heparin API Price by Type (2016-2021)

5 Global Heparin API Historic Market Analysis by Application
5.1 Global Heparin API Sales Market Share by Application (2016-2021)
5.2 Global Heparin API Revenue Market Share by Application (2016-2021)
5.3 Global Heparin API Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Hepalink
6.1.1 Hepalink Corporation Information
6.1.2 Hepalink Description and Business Overview
6.1.3 Hepalink Heparin API Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Hepalink Product Portfolio
6.1.5 Hepalink Recent Developments/Updates
6.2 Changshan Pharm
6.2.1 Changshan Pharm Corporation Information
6.2.2 Changshan Pharm Description and Business Overview
6.2.3 Changshan Pharm Heparin API Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Changshan Pharm Product Portfolio
6.2.5 Changshan Pharm Recent Developments/Updates
6.3 Qianhong Bio-pharma
6.3.1 Qianhong Bio-pharma Corporation Information
6.3.2 Qianhong Bio-pharma Description and Business Overview
6.3.3 Qianhong Bio-pharma Heparin API Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Qianhong Bio-pharma Product Portfolio
6.3.5 Qianhong Bio-pharma Recent Developments/Updates
6.4 Opocrin
6.4.1 Opocrin Corporation Information
6.4.2 Opocrin Description and Business Overview
6.4.3 Opocrin Heparin API Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Opocrin Product Portfolio
6.4.5 Opocrin Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Heparin API Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Pfizer Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Aspen Oss
6.6.1 Aspen Oss Corporation Information
6.6.2 Aspen Oss Description and Business Overview
6.6.3 Aspen Oss Heparin API Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Aspen Oss Product Portfolio
6.6.5 Aspen Oss Recent Developments/Updates
6.7 King-friend Biochemical Pharmaceutical
6.6.1 King-friend Biochemical Pharmaceutical Corporation Information
6.6.2 King-friend Biochemical Pharmaceutical Description and Business Overview
6.6.3 King-friend Biochemical Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2016-2021)
6.4.4 King-friend Biochemical Pharmaceutical Product Portfolio
6.7.5 King-friend Biochemical Pharmaceutical Recent Developments/Updates
6.8 Bioibérica
6.8.1 Bioibérica Corporation Information
6.8.2 Bioibérica Description and Business Overview
6.8.3 Bioibérica Heparin API Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Bioibérica Product Portfolio
6.8.5 Bioibérica Recent Developments/Updates
6.9 Dongcheng Biochemicals
6.9.1 Dongcheng Biochemicals Corporation Information
6.9.2 Dongcheng Biochemicals Description and Business Overview
6.9.3 Dongcheng Biochemicals Heparin API Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Dongcheng Biochemicals Product Portfolio
6.9.5 Dongcheng Biochemicals Recent Developments/Updates
6.10 Jiulong Biochemicals
6.10.1 Jiulong Biochemicals Corporation Information
6.10.2 Jiulong Biochemicals Description and Business Overview
6.10.3 Jiulong Biochemicals Heparin API Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Jiulong Biochemicals Product Portfolio
6.10.5 Jiulong Biochemicals Recent Developments/Updates
6.11 Tiandong
6.11.1 Tiandong Corporation Information
6.11.2 Tiandong Heparin API Description and Business Overview
6.11.3 Tiandong Heparin API Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Tiandong Product Portfolio
6.11.5 Tiandong Recent Developments/Updates
6.12 Xinbai
6.12.1 Xinbai Corporation Information
6.12.2 Xinbai Heparin API Description and Business Overview
6.12.3 Xinbai Heparin API Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Xinbai Product Portfolio
6.12.5 Xinbai Recent Developments/Updates
6.13 Yino Pharma Limited
6.13.1 Yino Pharma Limited Corporation Information
6.13.2 Yino Pharma Limited Heparin API Description and Business Overview
6.13.3 Yino Pharma Limited Heparin API Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Yino Pharma Limited Product Portfolio
6.13.5 Yino Pharma Limited Recent Developments/Updates

7 Heparin API Manufacturing Cost Analysis
7.1 Heparin API Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Heparin API
7.4 Heparin API Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Heparin API Distributors List
8.3 Heparin API Customers

9 Heparin API Market Dynamics
9.1 Heparin API Industry Trends
9.2 Heparin API Growth Drivers
9.3 Heparin API Market Challenges
9.4 Heparin API Market Restraints

10 Global Market Forecast
10.1 Heparin API Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Heparin API by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Heparin API by Type (2022-2027)
10.2 Heparin API Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Heparin API by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Heparin API by Application (2022-2027)
10.3 Heparin API Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Heparin API by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Heparin API by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables
Table 1. Global Heparin API Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Heparin API Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Heparin API Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Heparin API Covered in This Study
Table 5. Global Heparin API Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Heparin API Sales Share by Manufacturers (2016-2021)
Table 7. Global Heparin API Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Heparin API Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Heparin API Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Heparin API Manufacturing Sites and Area Served
Table 11. Manufacturers Heparin API Product Type
Table 12. Global Heparin API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Heparin API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heparin API as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Heparin API Sales by Region (2016-2021) & (K MT)
Table 16. Global Heparin API Sales Market Share by Region (2016-2021)
Table 17. Global Heparin API Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Heparin API Sales by Country (2016-2021) & (K MT)
Table 19. North America Heparin API Sales Market Share by Country (2016-2021)
Table 20. North America Heparin API Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Heparin API Revenue Market Share by Country (2016-2021)
Table 22. Europe Heparin API Sales by Country (2016-2021) & (K MT)
Table 23. Europe Heparin API Sales Market Share by Country (2016-2021)
Table 24. Europe Heparin API Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Heparin API Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Heparin API Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Heparin API Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Heparin API Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Heparin API Revenue Market Share by Region (2016-2021)
Table 30. Latin America Heparin API Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Heparin API Sales Market Share by Country (2016-2021)
Table 32. Latin America Heparin API Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Heparin API Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Heparin API Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Heparin API Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Heparin API Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Heparin API Revenue Market Share by Country (2016-2021)
Table 38. Global Heparin API Sales (K MT) by Type (2016-2021)
Table 39. Global Heparin API Sales Market Share by Type (2016-2021)
Table 40. Global Heparin API Revenue (Million US$) by Type (2016-2021)
Table 41. Global Heparin API Revenue Share by Type (2016-2021)
Table 42. Global Heparin API Price (USD/MT) by Type (2016-2021)
Table 43. Global Heparin API Sales (K MT) by Application (2016-2021)
Table 44. Global Heparin API Sales Market Share by Application (2016-2021)
Table 45. Global Heparin API Revenue (Million US$) by Application (2016-2021)
Table 46. Global Heparin API Revenue Share by Application (2016-2021)
Table 47. Global Heparin API Price (USD/MT) by Application (2016-2021)
Table 48. Hepalink Corporation Information
Table 49. Hepalink Description and Business Overview
Table 50. Hepalink Heparin API Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Hepalink Heparin API Product
Table 52. Hepalink Recent Developments/Updates
Table 53. Changshan Pharm Corporation Information
Table 54. Changshan Pharm Description and Business Overview
Table 55. Changshan Pharm Heparin API Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Changshan Pharm Heparin API Product
Table 57. Changshan Pharm Recent Developments/Updates
Table 58. Qianhong Bio-pharma Corporation Information
Table 59. Qianhong Bio-pharma Description and Business Overview
Table 60. Qianhong Bio-pharma Heparin API Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Qianhong Bio-pharma Heparin API Product
Table 62. Qianhong Bio-pharma Recent Developments/Updates
Table 63. Opocrin Corporation Information
Table 64. Opocrin Description and Business Overview
Table 65. Opocrin Heparin API Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Opocrin Heparin API Product
Table 67. Opocrin Recent Developments/Updates
Table 68. Pfizer Corporation Information
Table 69. Pfizer Description and Business Overview
Table 70. Pfizer Heparin API Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Pfizer Heparin API Product
Table 72. Pfizer Recent Developments/Updates
Table 73. Aspen Oss Corporation Information
Table 74. Aspen Oss Description and Business Overview
Table 75. Aspen Oss Heparin API Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Aspen Oss Heparin API Product
Table 77. Aspen Oss Recent Developments/Updates
Table 78. King-friend Biochemical Pharmaceutical Corporation Information
Table 79. King-friend Biochemical Pharmaceutical Description and Business Overview
Table 80. King-friend Biochemical Pharmaceutical Heparin API Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. King-friend Biochemical Pharmaceutical Heparin API Product
Table 82. King-friend Biochemical Pharmaceutical Recent Developments/Updates
Table 83. Bioibérica Corporation Information
Table 84. Bioibérica Description and Business Overview
Table 85. Bioibérica Heparin API Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. Bioibérica Heparin API Product
Table 87. Bioibérica Recent Developments/Updates
Table 88. Dongcheng Biochemicals Corporation Information
Table 89. Dongcheng Biochemicals Description and Business Overview
Table 90. Dongcheng Biochemicals Heparin API Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Dongcheng Biochemicals Heparin API Product
Table 92. Dongcheng Biochemicals Recent Developments/Updates
Table 93. Jiulong Biochemicals Corporation Information
Table 94. Jiulong Biochemicals Description and Business Overview
Table 95. Jiulong Biochemicals Heparin API Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. Jiulong Biochemicals Heparin API Product
Table 97. Jiulong Biochemicals Recent Developments/Updates
Table 98. Tiandong Corporation Information
Table 99. Tiandong Description and Business Overview
Table 100. Tiandong Heparin API Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 101. Tiandong Heparin API Product
Table 102. Tiandong Recent Developments/Updates
Table 103. Xinbai Corporation Information
Table 104. Xinbai Description and Business Overview
Table 105. Xinbai Heparin API Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 106. Xinbai Heparin API Product
Table 107. Xinbai Recent Developments/Updates
Table 108. Yino Pharma Limited Corporation Information
Table 109. Yino Pharma Limited Description and Business Overview
Table 110. Yino Pharma Limited Heparin API Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 111. Yino Pharma Limited Heparin API Product
Table 112. Yino Pharma Limited Recent Developments/Updates
Table 113. Production Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Heparin API Distributors List
Table 116. Heparin API Customers List
Table 117. Heparin API Market Trends
Table 118. Heparin API Growth Drivers
Table 119. Heparin API Market Restraints
Table 120. Global Heparin API Sales Forecast by Type (2022-2027) & (K MT)
Table 121. Global Heparin API Sales Market Share Forecast by Type (2022-2027)
Table 122. Global Heparin API Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 123. Global Heparin API Revenue Market Share Forecast by Type (2022-2027)
Table 124. Global Heparin API Sales Forecast by Application (2022-2027) & (K MT)
Table 125. Global Heparin API Sales Market Share Forecast by Application (2022-2027)
Table 126. Global Heparin API Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 127. Global Heparin API Revenue Market Share Forecast by Application (2022-2027)
Table 128. Global Heparin API Sales Forecast by Region (2022-2027) & (K MT)
Table 129. Global Heparin API Sales Market Share Forecast by Region (2022-2027)
Table 130. Global Heparin API Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 131. Global Heparin API Revenue Market Share Forecast by Region (2022-2027)
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Heparin API
Figure 2. Global Heparin API Market Share by Type in 2020 & 2027
Figure 3. Heparin Sodium Product Picture
Figure 4. Heparin Calcium Product Picture
Figure 5. Other Product Picture
Figure 6. Global Heparin API Market Share by Application in 2020 & 2027
Figure 7. UFH
Figure 8. LMWH
Figure 9. Global Heparin API Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Heparin API Market Size 2016-2027 (US$ Million)
Figure 11. Global Heparin API Sales 2016-2027 (K MT)
Figure 12. Global Heparin API Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Heparin API Sales Share by Manufacturers in 2020
Figure 14. Global Heparin API Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Heparin API Players: Market Share by Revenue in 2020
Figure 16. Heparin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Heparin API Sales Market Share by Region (2016-2021)
Figure 18. Global Heparin API Sales Market Share by Region in 2020
Figure 19. Global Heparin API Revenue Market Share by Region (2016-2021)
Figure 20. Global Heparin API Revenue Market Share by Region in 2020
Figure 21. U.S. Heparin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Heparin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Heparin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Heparin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Heparin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Heparin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Heparin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Heparin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Heparin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Heparin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Heparin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Heparin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Heparin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Heparin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Heparin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Heparin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Heparin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Heparin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Heparin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Heparin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Heparin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Heparin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Heparin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E Heparin API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Heparin API by Type (2016-2021)
Figure 46. Sales Market Share of Heparin API by Application (2016-2021)
Figure 47. Sales Market Share of Heparin API by Application in 2020
Figure 48. Revenue Share of Heparin API by Application (2016-2021)
Figure 49. Revenue Share of Heparin API by Application in 2020
Figure 50. Manufacturing Cost Structure of Heparin API
Figure 51. Manufacturing Process Analysis of Heparin API
Figure 52. Heparin API Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.